Literature DB >> 11784785

Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I.

Ward A Pedersen1, Ruiqian Wan, Peisu Zhang, Mark P Mattson.   

Abstract

Urocortin and urocortin II are members of the corticotropin-releasing hormone (CRH) family of neuropeptides that function to regulate stress responses. Two high-affinity G-protein-coupled receptors have been identified that bind CRH and/or urocortin I and II, designated CRHR1 and CRHR2, both of which are present in hippocampal regions of mammalian brain. The hippocampus plays an important role in regulating stress responses and is a brain region in which neurons are vulnerable during disease and stress conditions, including cerebral ischemia, Alzheimer's disease, and anxiety disorders. Here we report that urocortin exerts a potent protective action in cultured rat hippocampal neurons with concentrations in the range of 0.5-5.0 pm, increasing the resistance of the cells to oxidative (amyloid beta-peptide, 4-hydroxynonenal, ferrous sulfate) and excitotoxic (glutamate) insults. We observed that urocortin is 10-fold more potent than CRH in protecting hippocampal neurons from insult, whereas urocortin II is ineffective. RT-PCR and sequencing analyses revealed the presence of both CRHR1 and CRHR2 in the hippocampal cultures, with CRHR1 being expressed at much higher levels than CRHR2. Using subtype-selective CRH receptor antagonists, we provide evidence that the neuroprotective effect of exogenously added urocortin is mediated by CRHR1. Furthermore, we provide evidence that the signaling pathway that mediates the neuroprotective effect of urocortin involves cAMP-dependent protein kinase, protein kinase C, and mitogen-activated protein kinase. This is the first demonstration of a biological activity of urocortin in hippocampal neurons, suggesting a role for the peptide in adaptive responses of hippocampal neurons to potentially lethal oxidative and excitotoxic insults.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11784785      PMCID: PMC6758668     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  70 in total

Review 1.  Pathobiology of ischaemic stroke: an integrated view.

Authors:  U Dirnagl; C Iadecola; M A Moskowitz
Journal:  Trends Neurosci       Date:  1999-09       Impact factor: 13.837

2.  Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates.

Authors:  K E Habib; K P Weld; K C Rice; J Pushkas; M Champoux; S Listwak; E L Webster; A J Atkinson; J Schulkin; C Contoreggi; G P Chrousos; S M McCann; S J Suomi; J D Higley; P W Gold
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Corticotropin-releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaB.

Authors:  F Lezoualc'h; S Engert; B Berning; C Behl
Journal:  Mol Endocrinol       Date:  2000-01

4.  Concomitant changes in CRH mRNA levels in rat hippocampus and hypothalamus following immobilization stress.

Authors:  L Givalois; S Arancibia; L Tapia-Arancibia
Journal:  Brain Res Mol Brain Res       Date:  2000-01-10

5.  Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist.

Authors:  Y L Chen; R S Mansbach; S M Winter; E Brooks; J Collins; M L Corman; A R Dunaiskis; W S Faraci; R J Gallaschun; A Schmidt; D W Schulz
Journal:  J Med Chem       Date:  1997-05-23       Impact factor: 7.446

6.  Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins.

Authors:  D K Grammatopoulos; H S Randeva; M A Levine; K A Kanellopoulou; E W Hillhouse
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

7.  Corticotropin-releasing factor plays a permissive role in cerebellar long-term depression.

Authors:  M Miyata; D Okada; K Hashimoto; M Kano; M Ito
Journal:  Neuron       Date:  1999-04       Impact factor: 17.173

8.  Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins.

Authors:  D K Grammatopoulos; H S Randeva; M A Levine; E S Katsanou; E W Hillhouse
Journal:  Mol Endocrinol       Date:  2000-12

9.  G alphas-induced neurodegeneration in Caenorhabditis elegans.

Authors:  A J Berger; A C Hart; J M Kaplan
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

10.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity.

Authors:  M P Mattson; B Cheng; D Davis; K Bryant; I Lieberburg; R E Rydel
Journal:  J Neurosci       Date:  1992-02       Impact factor: 6.167

View more
  35 in total

Review 1.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

2.  Biological impact of low dose-rate simulated solar particle event radiation in vivo.

Authors:  P Y Chang; R Doppalapudi; J Bakke; A Wang; S Menda; Z Davis
Journal:  Radiat Environ Biophys       Date:  2010-05-16       Impact factor: 1.925

3.  Neonatal isolation accelerates the developmental switch in the signalling cascades for long-term potentiation induction.

Authors:  Chiung-Chun Huang; Pei-Hsuan Chou; Chih-Hao Yang; Kuei-Sen Hsu
Journal:  J Physiol       Date:  2005-10-13       Impact factor: 5.182

4.  Corticotropin-releasing factor and urocortin I activate CREB through functionally selective Gβγ signaling in hippocampal pyramidal neurons.

Authors:  Christopher M Stern; John Meitzen; Paul G Mermelstein
Journal:  Eur J Neurosci       Date:  2011-08-08       Impact factor: 3.386

Review 5.  Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction.

Authors:  Dimitris K Grammatopoulos
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 6.  Sex-dependent mental illnesses and mitochondria.

Authors:  Akiko Shimamoto; Virginie Rappeneau
Journal:  Schizophr Res       Date:  2017-03-06       Impact factor: 4.939

7.  α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B.

Authors:  Diana G Ferreira; Mariana Temido-Ferreira; Hugo Vicente Miranda; Vânia L Batalha; Joana E Coelho; Éva M Szegö; Inês Marques-Morgado; Sandra H Vaz; Jeong Seop Rhee; Matthias Schmitz; Inga Zerr; Luísa V Lopes; Tiago F Outeiro
Journal:  Nat Neurosci       Date:  2017-09-25       Impact factor: 24.884

Review 8.  Novel neuroprotective strategies in ischemic retinal lesions.

Authors:  Krisztina Szabadfi; Laszlo Mester; Dora Reglodi; Peter Kiss; Norbert Babai; Boglarka Racz; Krisztina Kovacs; Aliz Szabo; Andrea Tamas; Robert Gabriel; Tamas Atlasz
Journal:  Int J Mol Sci       Date:  2010-02-03       Impact factor: 6.208

Review 9.  Stress and the developing hippocampus: a double-edged sword?

Authors:  Kristen L Brunson; Yuncai Chen; Sarit Avishai-Eliner; Tallie Z Baram
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

10.  Mitogen-activated protein kinase signaling in the hippocampus and its modulation by corticotropin-releasing factor receptor 2: a possible link between stress and fear memory.

Authors:  Farahnaz Sananbenesi; André Fischer; Christina Schrick; Joachim Spiess; Jelena Radulovic
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.